THERESE JAECKLE: Open Payments
NPI 1063696516 · CEDARBURG, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,467 in 122 payments from 12 companies in 2025. Trend: 2023 $1,638 · 2024 $1,027 · 2025 $1,467
Food & beverage: $1,420Education: $47
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $316 |
| Neurocrine BioSciences, Inc. | 11 | $191 |
| Axsome Therapeutics, Inc. | 25 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $153 |
| Vanda Pharmaceuticals Inc. | 14 | $146 |
| Otsuka America Pharmaceutical, Inc. | 10 | $145 |
| Teva Pharmaceuticals USA, Inc. | 7 | $122 |
| Corium, LLC | 16 | $117 |
| Almatica Pharma LLC | 2 | $38 |
| Tris Pharma Inc | 2 | $32 |
Products named: VRAYLAR, INGREZZA, REXULTI, Auvelity, CAPLYTA, FANAPT, Azstarys, AUSTEDO XR.
Industry payments across WI — which companies pay providers there.
